JP-2022533072-A5 -

Dates

Publication Date

20230523

Application Date

20200514

Description

Treatment options for tear deficiency-type dry eye (ADDE) include the application of various artificial tears and the use of medications. Recently, the TrueTear transnasal electrical stimulation device, which is effective in treating dry eye, has been released. The following are prior art documents related to the invention of this application (including documents cited in the international phase after the international filing date and documents cited when the application was filed in other countries as national phase entries): (Prior art document) (Patent Document) (Patent Document 1) U.S. Patent No. 8,831,747 (Patent Document 2) U.S. Patent Application Publication No. 2018/0154161 (Patent Document 3) U.S. Patent Application Publication No. 2009/0099626 (Patent Document 4) U.S. Patent Application Publication No. 2017/0049619 (Patent Document 5) U.S. Patent Application Publication No. 2017/0087009 (Patent Document 6) U.S. Patent Application Publication No. 2015/0057701 (Patent Document 7) U.S. Patent Application Publication No. 2016/0339239 (Patent Document 8) International Publication No. 02/18008